News

KleverLab introduces a new line of PCR kits for the detection of Avian Infectious Bronchitis Virus (IBV) and the differentiation of vaccine strains

KleverLab introduces a new line of PCR kits for the detection of avian Infectious Bronchitis Virus (IBV) and the differentiation of vaccine strains.This new portfolio enables the detection of IBV in avian samples using the KleverVet IBV screen PCR Kit, as well as the accurate differentiation of vaccine strains, including variants QX, 4/91, Mass, D274, and 02. Examples of PCR efficiency in detecting and differentiating vaccine strains are demonstrated in Figure 1 and Table 1.Figire 1. Results of testing samples confirmed...

August 6, 2026

Read more +

KleverLab Introduces first PCR Kit to Detect and Differentiate Key Bacillus cereus Virulence Markers

KleverTest Bacillus cereus DiTox PCR Kit delivers rapid, qualitative detection and differentiation of virulence-associated toxin genes in Bacillus cereus isolates. This advanced kit enables swift genetic characterization of B. cereus pathotypes by targetting key virulence markers: nheA (non-hemolytic enterotoxin), hblD (hemolysin BL), cytK1/cytK2 (cytolysin variants 1 and 2), and ces (cereulide synthase/emetic toxin marker) Examples of the PCR efficiency in detecting and differentiating virulence-associated toxin genes in Bacillus cereus are shown in Figures 1–4. Figure 1. Results of positive control amplification of...

July 10, 2026

Read more +

KleverLab introduces lyo-ready and lyophilized Fast Probe qPCR mastermixes

We are expanded FastProbe products line with new lyo-Ready and lyophilized qPCR mastermixes. The new portfolio includes lyophilized Fast Probe Lyo qPCR Mastermix and Fast Probe U Lyo qPCR Mastermix which can be stored at room temperature and 5X Fast Probe Lyo-Ready qPCR Mastermix with 5X Fast Probe U Lyo-Ready qPCR Mastermix for in-house production of fully lyophilized PCR mixes and kits.Comparison of PCR results obtained with 5X Fast Probe Lyo-Ready qPCR Mastermix (green), mastermix after lyophilization and subsequent reconstitution...

June 15, 2026

Read more +

We are thrilled to announce our participation in World Health Expo Dubai 2026 (WHX)

Mark your calendars for the greatest professional event of the year – World Health Expo Dubai 2026 (WHX) in Dubai, UAE.📅 10-13 February, 2026 📍Our booth SA.j53We are confident that our expertise and product range will prove both valuable and engaging for all visitors to our stand at this exhibition. This is a warm invitation to meet our team in person and explore our latest offerings. Join us at WHX LABS DUBAI 2026!

December 15, 2025

Read more +

Kleverlab Attends the Medica 2025 Fair in Düsseldorf, Germany

At Medica 2025 in Düsseldorf, Germany, Kleverlab reached a significant milestone by unveiling its latest product series. As a key participant in this premier international trade fair, the company showcased its newest advancements in PCR diagnostics to a global audience. Throughout the event, Kleverlab's expert team engaged with attendees, offering comprehensive insights into the practical applications and technical advantages of these diagnostic solutions. The exhibition served as a vital platform for the company to exchange industry knowledge, forge strategic partnerships, and...

December 10, 2025

Read more +

We are pleased to announce our participation in MEDICA – Leading International Trade Fair 2025!

Mark your calendars for the greatest professional event of the year – Medica Trade Fair in Düsseldorf, Germany.📅 17-20 November, 2025 📍Our booth 3F17We believe that our expertise and products would be a valuable asset for your company. This is a warm invitation to meet our team in person and explore our latest offerings. Join us at MEDICA 2025!

July 30, 2025

Read more +

The KleverTest ASFV PCR Kit has been successfully validated by CISA-INIA/CSIC, the EU Reference Laboratory for ASF (EURL-ASF)

Validation of the KleverTest ASFV PCR Kit confirmed its ability to detect a broad range of ASFV variants, accurately identifying 21 out of 24 known p72 genotypes with 100% sensitivity. The kit was also tested on 268 reference samples, 291 field samples, and 40 negative samples from INIA-CISA (including blood and various tissue samples from infected domestic pigs and wild boars). It demonstrated a diagnostic sensitivity of 98.6% and a specificity of 97.5% compared to the WOAH-UPL reference method.

February 7, 2025

Read more +

Kleverlab at Medlab 2025 – See You in Dubai!

Kleverlab will once again attend Medlab Middle East 2025, taking place from February 3 to 6 in Dubai. We look forward to meeting our partners, holding negotiations, discussing new collaboration opportunities, and presenting our latest developments.📍 Place: Dubai World Trade Centre 📅 Dates: February 3–6, 2025

January 30, 2025

Read more +

Kleverlab participated in Medica 2024, held in Düsseldorf, Germany

Kleverlab successfully announced a new line of products at the international trade fair Medica 2024, which takes place annually in Düsseldorf.Our company’s specialists provided detailed information about the latest solutions for PCR diagnostics and their effective application to visitors.Participation in the exhibition was an effective opportunity for Kleverlab to present, share experiences with international colleagues, establish new business contacts and discuss prospects for cooperation.You can order our products on our website now.

December 26, 2024

Read more +

Kleverlab introduces the new RiboBlock H RNase Inhibitor

RiboBlock H RNase Inhibitor is a 50 kDa recombinant protein of humane origin. Due to genetic modification, RiboBlock H RNase Inhibitor does not contain the pair of cysteines found in the human native version, which is highly sensitive to oxidation. As a result, RiboBlock H RNase Inhibitor has significantly improved resistance to oxidation and increased stability during storage. Experiments have shown that RiboBlock H RNase Inhibitor retains its activity after storage at 37°C for 30 days and at 4°C for...

October 1, 2024

Read more +